Device Trial Radar · NCT04793893
Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery
Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
42
Actual
Start
Jan 8, 2017
Primary completion
Jan 8, 2018
Study completion Sep 8, 2027
Sponsor
- Lead sponsor
- Eye Hospital Pristina KosovoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 11, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
LASIK (laser-assisted in situ keratomileusis) is a type of refractive surgery for correction of myopia, hyperopia and astigmatism. Yet approximately 30% of operated patients have symptoms like glare, halos, dry eyes and especially residual hypermetrop refractive errors. Residual hypermetrop refractive errors are difficult to treat surgically, the current treatment is Refractive Lens Implantation - risks are similar to those of cataract surgery (endophthalmitis, loss of accommodation, etc.)
Conditions
- Refractive Errors
Interventions
ReLex SmileDevice
With the ReLex Smile the optical zone (lenticule diameter) and cap diameter are 6.5 and 7.5 mm respectively. After dissection of both anterior and posterior planes, the lenticule is extracted through 120 degree superior 3.5 mm incision and marked with a sterile marker (ViscotMedster). This retrospective case series included 84 eyes of 42 patients (15 male, 27 female; mean age 32.9 ± 7.5 years, range 22-44 years) who underwent positive meniscus-shaped lenticule transplantation for correction of residual hyperopia and presbyopia following prior hyperopic LASIK between January 2017 and December 2018. Of these, 13 patients (31.0%) were aged ≥40 years with established presbyopia. Preoperative refractive error was +3.68 ± 1.32 D (range +1.00 to +6.00 D) with a mean cylinder of +1.36 ± 0.43 D (range +0.75 to +2.00 D). Mean preoperative central corneal thickness was 493.87 ± 34.04 µm (range 440-560 µm).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Increase of visual acuityTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Eye Hospital Pristina
Pristina, Kosovo
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.